CereVasc shared data from a study demonstrating that its eShunt system may help deliver gene therapies to the central nervous ...

The Orphan Drug designation is supported by positive preclinical data from bleomycin-induced mouse models and patient-derived skin fibroblasts.

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon’s entry ...